DONOR EGG IVF (IN-VITRO FERTILIZATION) MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Donor Egg IVF (In-Vitro Fertilization) Market, By Cycle Type (Fresh Donor Egg IVF Cycle and Frozen Donor Egg IVF Cycle), By Pricing Model (Pay-Per-Cycle and Bundled Package), By Age Group (21-35 Years, 36-40 Years, 41-45 Years), By End User (Fertility Clinics, Hospitals, Surgical Centers, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Sep 2024
Code : CMI7359
Pages :144
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Donor Egg IVF (In-Vitro Fertilization) Market Regional Insights

To learn more about this report, request sample copy

North America dominates the global donor egg IVF (in-vitro fertilization) market with an estimated market share of 40.3% in 2024, due to strong industry presence and favourable reimbursement policies. The U.S. accounts for majority of market share in the region, owing to growing acceptance of third-party reproduction and presence of major industry players. Many leading fertility clinics in the country offer donor egg programs that attract patients from other parts of the world as well. Flexible financing options make critical infertility treatments affordable for residents. This has boosted demand. Though regulations vary at state level, overall supportive regulatory environment and patent protection for new techniques have encouraged ongoing R&D investments.

Asia Pacific region is poised to be the fastest growing market during the forecast period. Countries like China, India and Japan can drive the market growth due to rising infertility rates attributable to changing lifestyle habits. Growing medical tourism also attracts patients from foreign countries to available fertility treatments at lower costs. While practices are new to some eastern cultures, changing social attitudes and strong economic growth are helping overcome taboos. Governments in various developing nations have formulated favorable guidelines to regulate this sector and promote domestic innovation. Regional players are partnering with global in-vitro fertilization providers to transfer technologies and skills. This is expected to boost localized production and research capabilities to cater to future needs. Improving accessibility in tier 2 and 3 cities further expands the potential patient pool.